CI 10-Q Quarterly Report March 31, 2020 | Alphaminr
ALPHAMINR

CI 10-Q Quarter ended March 31, 2020

Balance Sheet
Cash Flow
Income Statement
Debt
TABLE OF CONTENTS
Part IItem 1. Financial StatementsNote 1 Description Of BusinessNote 2 Covid-19 and Related Economic ImpactNote 3 Summary Of Significant Accounting PoliciesNote 4 - Accounts Receivable, NetNote 5 Mergers and AcquisitionsNote 6 Assets and Liabilities Of Business Held For SaleNote 7 Earnings Per Share ( Eps )Note 8 DebtNote 9 Insurance and Contractholder LiabilitiesNote 10 ReinsuranceNote 11 InvestmentsNote 12 Fair Value MeasurementsNote 13 Variable Interest EntitiesNote 14 Accumulated Other Comprehensive Income (loss) ( Aoci )Note 15 - Organizational Efficiency PlanNote 16 PensionNote 17 LeasesNote 18 Income TaxesNote 19 Contingencies and Other MattersNote 20 Segment InformationItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II. Other InformationPart IIItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 6. Exhibits

Exhibits

4.1 Fourth Supplemental Indenture, dated as of March 16, 2020, between Cigna Corporation and U.S. Bank National Association, as Trustee Filed by the registrant as Exhibit 4.1 to the Current Report on Form 8-K on March 16, 2020 and incorporated herein by reference. 10.1* Form of Cigna Long-Term Incentive Plan: Strategic Performance Share Grant Agreement Filed herewith. 10.2* Form of Cigna Long-Term Incentive Plan: Nonqualified Stock Option Grant Agreement Filed herewith. 10.3* Form of Cigna Long-Term Incentive Plan: Restricted Stock Grant Agreement Filed herewith. 10.4* Form of Cigna Long-Term Incentive Plan: Restricted Stock Unit Grant Agreement Filed herewith. 10.5* Form of Cigna Long-Term Incentive Plan: Covenant Agreement Filed herewith. 10.6* Agreement and Release between the Company and Lisa Bacus dated June 10, 2019 Filed herewith. 31.1 Certification of Chief Executive Officer of Cigna Corporation pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 Filed herewith. 31.2 Certification of Chief Financial Officer of Cigna Corporation pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 Filed herewith. 32.1 Certification of Chief Executive Officer of Cigna Corporation pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350 Furnished herewith. 32.2 Certification of Chief Financial Officer of Cigna Corporation pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350 Furnished herewith.